LONDON, 14 September (
The researchers noted that the benefits of the treatment were not immediate: even patients who eventually experienced success with the treatment had their tumours grow immediately after transplantation, when their immune systems were still weak. Regression of tumours did not occur until four months after cessation of immune-suppressing drugs, and the procedure was not risk-free, with two recipients dying from transplant-related causes. The authors conclude that, for the...